What Does ChatGPT for Clinicians Say About BPH Therapies?
In urology practice, explaining how a BPH therapy works is only the beginning. The next questions concern patient selection, anatomy, contraindications, and the tradeoffs that matter to the person considering treatment.
When I heard about ChatGPT for Clinicians, OpenAI’s clinician-focused offering, I was curious: what would its answers look like, and how would they differ from the ChatGPT responses I was familiar with? To explore that question, I used ChatGPT Pro as a reference point and gave both the same prompt:
“Tell me about the therapies in the AUA BPH guidelines and explain each one briefly.”
This was an informal experiment with friends, each of us using our own ChatGPT account, rather than a formal evaluation. I have no affiliation with or financial interest in OpenAI, and OpenAI neither sponsored this article nor compensated me for it.
The two responses covered broadly similar ground: lifestyle measures, medications, and procedures. What stood out was the difference in emphasis.
The Pro response focused on “What is this therapy?” The Clinician response went further toward “Which patient is it for?”
What the Pro response did
The Pro response explained mechanisms in plain language. An alpha blocker relaxes muscle around the bladder outlet. Water vapor treatment shrinks prostate tissue. Implants hold tissue apart.
It defined BPH, noted that urgency and nocturia can have other causes, and largely described each option without comparing one procedure with another. The result read more like an introductory explanation than a treatment-selection reference.
This is the kind of explanation a patient might bring to a urology appointment, although the guideline-specific prompt and advanced setup used here should not be taken as representative of a typical patient’s ChatGPT experience.
For someone who routinely counsels patients about BPH, the mechanisms will be familiar. The interest is in how the response translates them into accessible language.
What the Clinician response added
The Clinician response retained the mechanisms and added more of the context relevant to treatment selection and counseling:
Eligibility: prostate volume and anatomy for most procedures, such as PUL for 30–80 cc without an obstructing median lobe, PAE for glands of 50 cc or more, and 5-ARIs for volume above 30 cc and/or PSA above 1.5 ng/mL.
Recommendation strength: it flags which options are conditional, including tadalafil combinations, the drug-coated balloon, and PAE.
Counseling points: floppy iris syndrome with alpha blockers, roughly 50% PSA suppression with 5-ARIs, the nitrate contraindication with tadalafil, and blood pressure with mirabegron.
Structure: procedures are split into two groups, those that remove tissue and those that limit tissue disruption or aim to preserve ejaculation.
Boundaries: when a procedure becomes necessary (renal impairment, refractory retention, recurrent infection, stones, or hematuria) and which technologies sit outside the active recommendations.
These details change the usefulness of a summary. They bring it closer to the questions that arise when reviewing options for an individual patient.
What caught my attention
My curiosity began with what “for Clinicians” might mean in an actual response. In this example, what caught my attention was how much of the surrounding clinical context appeared alongside each therapy.
The mechanisms were familiar. The additional layer was the attention to eligibility, cautions, and counseling considerations: details that matter when moving from an explanation of a treatment to a discussion of its suitability for a patient. Reading the Pro response alongside it made that difference easier to see.
This is one example, not a conclusion about how either product will answer every clinical question. But it offered a concrete glimpse of what a clinician-focused response can look like.
Neither replaces the guideline itself or the clinical judgment required to apply it. But the comparison highlights a distinction that matters in urology: explaining a treatment and placing it in the context of a patient’s care are different tasks.
Both ChatGPT versions used the same underlying inference model, Astra, but the responses differed in emphasis and clinical detail.
Read both companion articles
I’m sharing both articles so readers can examine the differences for themselves:
From treatment information to a patient’s own records
At Soundable Health, I’m interested in how patients can bring useful information about their own urinary health into these conversations. proudP enables smartphone-based home uroflow tracking, with results patients can share with their urologist.
Curious about the patient experience?
